Unraveling mysteries of pancreatic cancer’s resistance to standard therapies

In a new study, researchers have illuminated one of pancreatic cancer’s major resistance mechanisms: a form of inflammation that is triggered by the tumor in response to treatment and helps keep tumor cells alive. Blocking this inflammation after radiation therapy brought a significant improvement in survival in a mouse model of the disease. (Mehr in: Cancer News — ScienceDaily)